# Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)

> **NCT05253781** · PHASE3 · COMPLETED · sponsor: **University of Lagos, Nigeria** · enrollment: 476 (actual)

## Conditions studied

- Intrauterine Growth Restriction
- Preeclampsia
- Sickle Cell Disease
- Pregnancy Complications

## Interventions

- **DRUG:** Low-dose aspirin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05253781
- **Lead sponsor:** University of Lagos, Nigeria
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2024-10-29
- **Final completion:** 2024-11-21
- **Target enrollment:** 476 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05253781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05253781, "Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05253781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*